» Articles » PMID: 32260543

Neuroprotective Effect of Bergamot Juice in 6-OHDA-Induced SH-SY5Y Cell Death, an Model of Parkinson's Disease

Overview
Journal Pharmaceutics
Publisher MDPI
Date 2020 Apr 9
PMID 32260543
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Much evidence suggests that both oxidative stress and apoptosis play a key role in the pathogenesis of Parkinson's disease (PD). The present study aims to evaluate the protective effect of bergamot juice (BJ) against 6-hydroxydopamine (6-OHDA)- or HO-induced cell death. Treatment of differentiated SH-SY5Y human neuroblastoma cells with 6-OHDA or HO resulted in cell death that was significantly reduced by the pre-treatment with BJ. The protective effects of BJ seem to correlate with the reduction of intracellular reactive oxygen species and nitric oxide generation caused by 6-OHDA or HO. BJ also attenuated mitochondrial dysfunction, caspase-3 activation, imbalance of pro- and anti-apoptotic proteins, MAPKs activation and reduced NF-ĸB nuclear translocation evoked by neurotoxic agents. Additionally, BJ exhibited excellent antioxidant capability in assays. Collectively, our results suggest that BJ exerts neuroprotective effect through the interplay with specific cell targets and its antioxidant activity, making it worthy of consideration for the management of neurodegenerative diseases.

Citing Articles

Robust In Vitro Models for Studying Parkinson's Disease? LUHMES Cells and SH-SH5Y Cells.

Keighron C, Avazzedeh S, Quinlan L Int J Mol Sci. 2024; 25(23).

PMID: 39684831 PMC: 11642316. DOI: 10.3390/ijms252313122.


The protective effect of parthenolide in an in vitro model of Parkinson's disease through its regulation of nuclear factor-kappa B and oxidative stress.

Shariat Razavi S, Vafaei F, Ebrahimi S, Abbasinezhad-Moud F, Shahini A, Qoorchi Moheb Seraj F Mol Biol Rep. 2024; 51(1):819.

PMID: 39017801 DOI: 10.1007/s11033-024-09779-w.


Protective Effect of Arzanol against HO-Induced Oxidative Stress Damage in Differentiated and Undifferentiated SH-SY5Y Cells.

Piras F, Sogos V, Pollastro F, Rosa A Int J Mol Sci. 2024; 25(13).

PMID: 39000492 PMC: 11242736. DOI: 10.3390/ijms25137386.


Optimization of the Preparation Process of Glucuronomannan Oligosaccharides and Their Effects on the Gut Microbiota in MPTP-Induced PD Model Mice.

Wang B, Geng L, Wang J, Wei Y, Yan C, Wu N Mar Drugs. 2024; 22(5).

PMID: 38786584 PMC: 11123026. DOI: 10.3390/md22050193.


Mitochondrial dysfunction-targeting therapeutics of natural products in Parkinson's disease.

He T, Lin X, Su A, Zhang Y, Xing Z, Mi L Front Pharmacol. 2023; 14:1117337.

PMID: 37234707 PMC: 10206024. DOI: 10.3389/fphar.2023.1117337.


References
1.
Ferlazzo N, Cirmi S, Calapai G, Ventura-Spagnolo E, Gangemi S, Navarra M . Anti-Inflammatory Activity of Citrus bergamia Derivatives: Where Do We Stand?. Molecules. 2016; 21(10). PMC: 6274179. DOI: 10.3390/molecules21101273. View

2.
Mulvihill E, Burke A, Huff M . Citrus Flavonoids as Regulators of Lipoprotein Metabolism and Atherosclerosis. Annu Rev Nutr. 2016; 36:275-99. DOI: 10.1146/annurev-nutr-071715-050718. View

3.
Guo J, Zhao X, Li Y, Li G, Liu X . Damage to dopaminergic neurons by oxidative stress in Parkinson's disease (Review). Int J Mol Med. 2018; 41(4):1817-1825. DOI: 10.3892/ijmm.2018.3406. View

4.
Ciulla M, Marinelli L, Cacciatore I, Di Stefano A . Role of Dietary Supplements in the Management of Parkinson's Disease. Biomolecules. 2019; 9(7). PMC: 6681233. DOI: 10.3390/biom9070271. View

5.
Condello S, Calabro E, Caccamo D, Curro M, Ferlazzo N, Satriano J . Protective effects of agmatine in rotenone-induced damage of human SH-SY5Y neuroblastoma cells: fourier transform infrared spectroscopy analysis in a model of Parkinson's disease. Amino Acids. 2011; 42(2-3):775-81. DOI: 10.1007/s00726-011-0994-z. View